News Image

Apogee Therapeutics Announces Agenda for Virtual R&D Day

Provided By GlobeNewswire

Last update: Nov 29, 2024

SAN FRANCISCO and WALTHAM, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD) and other I&I indications, today announced the agenda for its upcoming virtual R&D Day being held on Monday, December 2, 2024 at 10:00 a.m. ET.

Read more at globenewswire.com

APOGEE THERAPEUTICS INC

NASDAQ:APGE (6/10/2025, 4:04:07 PM)

After market: 42.02 0 (0%)

42.02

+1.89 (+4.71%)



Find more stocks in the Stock Screener

Follow ChartMill for more